Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-27 @ 11:13 PM
Study NCT ID:
NCT06927960
Status:
COMPLETED
Last Update Posted:
2025-12-19
First Post:
2025-04-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Dose Administration
Sponsor:
AnHorn Medicines Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-24
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-16
Completion Date Type:
ACTUAL
First Submit Date:
2025-04-07
First Submit QC Date:
None
Study First Post Date:
2025-04-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-15
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED